Novo Nordisk
NVO
644 hedge funds and large institutions have $9.51B invested in Novo Nordisk in 2020 Q1 according to their latest regulatory filings, with 72 funds opening new positions, 164 increasing their positions, 281 reducing their positions, and 61 closing their positions.
62% more funds holding in top 10
Funds holding in top 10: 13 → 21 (+8)
18% more call options, than puts
Call options by funds: $30.8M | Put options by funds: $26.1M
18% more first-time investments, than exits
New positions opened: 72 | Existing positions closed: 61
1% more funds holding
Funds holding: 640 → 644 (+4)
4% less capital invested
Capital invested by funds: $9.91B → $9.51B (-$400M)
1.41% less ownership
Funds ownership: 18.37% → 16.96% (-1.4%)
42% less repeat investments, than reductions
Existing positions increased: 164 | Existing positions reduced: 281
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$97.9M |
| 2 |
Jane Street
New York
|
+$29.1M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$21.2M |
| 4 |
OMC
Old Mission Capital
Chicago,
Illinois
|
+$17.3M |
| 5 |
Capital International Investors
Los Angeles,
California
|
+$16.8M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
-$317M |
| 2 |
SGA
Sustainable Growth Advisers
Stamford,
Connecticut
|
-$135M |
| 3 |
Alyeska Investment Group
Chicago,
Illinois
|
-$62.2M |
| 4 |
AAMU
Amundi Asset Management US
Boston,
Massachusetts
|
-$56.6M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$54.4M |
NVO Hedge Fund Activity: Q1 2020 in Review
644 of the 4,547 institutional investors tracked by Wall St. Rank reported a position in Novo Nordisk (NVO) for Q1 2020, worth a combined $9.51B — down 4% from $9.91B a quarter earlier.
Buyers outnumbered sellers: 72 funds opened new NVO positions and 61 closed out — a net gain of 11 holders — while 164 added to existing stakes and 281 trimmed.
The largest buyer was Renaissance Technologies, adding an estimated $97.9M. The largest seller was Loomis, Sayles & Company, cutting an estimated $317M.
- 644 institutional investors held Novo Nordisk (NVO) as of Q1 2020, up from 640 in Q4 2019.
- Funds reported $9.51B of Novo Nordisk stock for Q1 2020, down 4% quarter-over-quarter.
- 72 funds opened new Novo Nordisk positions in Q1 2020 and 61 closed out, a net change of +11 holders.
- The largest Novo Nordisk buyer in Q1 2020 was Renaissance Technologies, an estimated $97.9M added.
- The largest Novo Nordisk seller in Q1 2020 was Loomis, Sayles & Company, an estimated $317M sold.
Based on aggregated 13F filings for Q1 2020.